Stay updated with breaking news from Peter Melnyk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
September 27, 2023 Dear Alpha Tau Medical Ltd. Shareholders: We cordially invite you to attend the annual general meeting of shareholders of Alpha Tau Medical...
(2022-11-22 | NDAQ:DRTS) Alpha Tau Medical Announces Third Quarter 2022 Financial Results and Provides Corporate Update
JERUSALEM, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer...
JERUSALEM, Sept. 01, 2022 -- Alpha Tau Medical Ltd. , the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that Peter Melnyk, a member of its board of... | September 1, 2022
Alpha Tau Medical Announces Appointment of Peter Melnyk as New Board Member USA - English Share this article Share this article JERUSALEM, Jan. 12, 2021 /PRNewswire/ -- Alpha Tau Medical, the developer of breakthrough Alpha DaRT (Diffusing alpha-emitters Radiation Therapy), is pleased to announce the appointment of Peter Melnyk to its Board of Directors. Mr. Melnyk is the CEO of Fortovia Therapeutics, a commercial stage, private equity-owned pharmaceutical company focused on oncology supportive care products. Prior to that, he held leading roles in sales, marketing, and business development i...